Researchers are beginning a highly anticipated study of two possible treatments for the Ebola outbreak in eastern Congo

The Bundibugyo strain has no approved vaccine or targeted treatment, leaving supportive care as the primary option.

More than 1,400 people have been diagnosed and 438 have died